We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TYGO:NASDAQTigo Energy, Inc. Analysis

Data as of 2026-08-31 - not real-time

$1.07

Latest Price

9/10Risk

Risk Level: High

Executive Summary

At $1.07, Tigo Energy, Inc. shows a bearish moving-average alignment, with shorter averages beneath longer ones. The last 30 days have lost 36.3%. Momentum indicators put RSI at 31.7 (approaching oversold) with MACD reading bullish. The recent range runs from support at $0.9300 up to resistance at $2.09.
The shares look undervalued, trading on 6.7 times earnings below a sector average of 35.7. Consensus targets land 164.0% above where the shares trade now. Revenue is growing at 5.6% on a 9.0% profit margin.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 149.8%, a beta of 2.30 and a maximum drawdown of 79.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons diverge: hold near-term but buy on a long view, at 5/10 conviction over the longer horizon.

Top Market Events

Updated Aug 4, 2026 0 LOS GATOS, Calif.-- BUSINESS WIRE --Aug 4, 2026-- Tigo Energy, Inc. "Tigo" or the "Company"...Despite a challenging quarter and revised guidance, Tigo Energy Inc TYGO leverages regulatory tailwinds and disciplined...Residential solar weakness pressured revenue despite geographic diversification efforts.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 2.79
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 6.7 versus sector average of 35.7
  • Trading below the 200-day average of 2.79

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 6.7 versus sector average of 35.7
  • Analyst targets imply +164.0% versus the current price
  • Return on equity of 43.1%

Key Metrics & Analysis

Financial Health

Revenue Growth5.60%
Profit Margin8.97%
P/E Ratio6.7
ROE43.06%
ROA-2.45%
Debt/Equity14.52
P/B Ratio2.0
Op. Cash Flow$-7235000
Free Cash Flow$8.9M
Industry P/E35.7

Technical Analysis

TrendBearish
RSI31.7
Support$0.93
Resistance$2.09
MA 20$1.20
MA 50$1.66
MA 200$2.79
MACDBullish
VolumeDecreasing
Fear & Greed Index94.3

Valuation

Fair Value$2.02
Target Price$2.83
Upside/Downside164.02%
GradeUndervalued
TypeBlend

Risk Assessment

Beta2.30
Volatility149.80%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.